[1] |
Oudkerk M, Liu S, Heuvelmans MA, et al. Lung cancer LDCT screening and mortality reduction-evidence, pitfalls and future perspectives[J]. Nat Rev Clin Oncol, 2021, 18(3): 135-151.
|
[2] |
Hyuna S, Jacques F, Rebecca LS, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249.
|
[3] |
Kakinuma R, Noguchi M, Ashizawa K, et al. Natural history of pulmonary subsolid nodules: a prospective multicenter study[J]. J Thorac Oncol, 2016, 11(7): 1012-1028.
|
[4] |
Lee HW, Jin KN, Lee JK, et al. Long-term follow-up of ground-grass nodules after 5 years of stability[J]. J Thorac Oncol, 2019, 14(8): 1370-1377.
|
[5] |
Dai J, Yu G, Yu J. Can CT imaging features of ground-glass ocpacity predict invasiveness? A meta-analysis[J]. Thoracic Cancer, 2018, 9(4): 452-458.
|
[6] |
Pellicano R, Ianiro G, Fagoonee S, et al. Review: Extragastric diseases and Helicobacter pylori[J]. Helicobacter, 2020, 25(Suppl 1): e12741.
|
[7] |
Buzás GM. Helicobacter pylori and non-alcoholic fatty liver disease[J]. Minerva Gastroenterol Dietol, 2020, 66: 267-279.
|
[8] |
Zuo ZT, Ma Y, Sun Y, et al. The protective effects of Helicobacter pylori infection on allergic asthma[J]. Int Arch Allergy Immunol, 2021, 182: 53-64.
|
[9] |
Doulberis M, Papaefthymiou A, Polyzos SA, et al. Association between active Helicobacter pylori infection and glaucoma: A systematic review and meta-analysis[J]. Microorganisms, 2020, 8: 894.
|
[10] |
Doulberis M, Kotronis G, Gialamprinou D, et al. Alzheimer’s disease and gastrointestinal microbiota; impact of Helicobacter pylori infection involvement[J]. Int J Neurosci, 2021, 131: 289-301.
|
[11] |
Mounika P. Helicobacter pylori infection and risk of lung cancer: A meta-analysis[J]. Lung Cancer Int, 2013, 2013: 131869.
|
[12] |
中华医学会呼吸病学分会肺癌学组, 中国肺癌防治联盟专家组. 肺结节诊治中国专家共识(2018年版)[J]. 中华结核和呼吸杂志, 2018, 41(10): 763-771.
|
[13] |
Chen Y, Segers S, Blaser MJ. Association between Helicobacter pylori and mortality in the NHANES Ⅲ study[J]. Gut, 2013, 62(9): 1262-1269.
|
[14] |
Philippou N, Koursarakos P, Anastasakou E, et al. Helicobacter pylori seroprevalence in patients with lung cancer[J]. World J Gastroenterol, 2004, 10(22): 3342-3344.
|
[15] |
Najafizadeh K, Falah Tafti S, Shiehmorteza M, et al. H pylori seroprevalence in patients with lung cancer[J]. World J Gastroenterol, 2007, 13(16): 2349-2351.
|
[16] |
Koshiol J, Flores R, Lam TK, et al. Helicobacter pylori seropositivity and risk of lung cancer[J]. PLoS One, 2012, 7(2): e32106.
|
[17] |
Sun S, Schiller J, Gazdar A. Lung cancer in never smokers-a different disease[J]. Nat Rev Cancer, 2007, 7(10): 778-790.
|
[18] |
Shi Z, Deng J, She Y, et al. Quantitative features can predict further growth of persistent pure ground-glass nodule[J]. Quant Imaging Med Surg, 2019, 9(2): 283-291.
|
[19] |
Ece F, F Hatabay N, Erdal N, et al. Does Helicobacter pylori infection play a role in lung cancer?[J]. Respir Med, 2005, 99(10): 1258-1262.
|
[20] |
Gocyk W, Niklifiski T, Olechnowicz H, et al. Helicobacter pylori, gastrin and cyclooxygenase-2 in lung cancer[J]. Med Sci Monit, 2000, 6(6): 1085-1092.
|
[21] |
Behroozian R, Moradkhan E. The assessment of probable relationship between lung cancer and Helicobacter pylori infection[J]. Trop Gastroenterol, 2010, 31(1): 34-36.
|
[22] |
Janssen-Heijnen ML, Coebergh JW. The changing epidemiology of lung cancer in Europe[J]. Lung Cancer, 2003, 41: 245-258.
|
[23] |
Sugimoto M, Uotani T, Ichikawa H, et al. Gastroesophageal reflux disease in time covering eradication for all patients infected with Helicobacter pylori in Japan[J]. Digestion, 2016, 93(1): 24-31.
|
[24] |
孔洋洋, 刘立新. 胃食管反流病患者幽门螺杆菌感染率的Meta分析[J/OL]. 中华消化病与影像杂志(电子版), 2017, 7(5): 205-210.
|
[25] |
Ravelli AM, Panarotto MB, Verdoni L, et al. Pulmonary aspiration shown by scintigraphy in gastroesophageal reflux-related respiratory disease[J]. Chest, 2006, 130(5): 1520-1526.
|
[26] |
Kim J, Lee JH, Kim Y, et al. Association between chronic obstructive pulmonary disease and gastroesophageal reflux disease: a national cross-sectional cohort study[J]. BMC Pulm Med, 2013, 13: 51.
|
[27] |
Ates F, Vaezi MF. Insight into the relationship between gastroesophageal reflux disease and asthma[J]. Gastroenterol Hepatol (NY), 2014, 10(11): 729-736.
|
[28] |
Lee JS, Collard HR, Anstrom KJ, et al. Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials[J]. Lancet Respir Med, 2013, 1(5): 369-376.
|
[29] |
Linz B, Balloux F, Moodley Y, et al. An African origin for the intimate association between human and Helicobacter pylori[J]. Nature, 2007, 445: 915-918.
|
[30] |
Kayhan B, Arasli M, Eren H, et al. Analysis of peripheral blood lymphocyte phenotypes and Th1/Th2 cytokines profile in the systemic immune responses of Helicobacter pylori infected individuals[J]. Microbiol Immunol, 2008, 52: 531-538.
|
[31] |
Nakashima S, Kakugawa T, Yura H, et al. Identification of Helicobacter pylori VacA in human lung and its effects on lung cells[J]. Biochem Biophys Res Commun, 2015, 460(3): 721-726.
|
[32] |
Altobelli A, Bauer M, Velez K, et al. Helicobacter pylori VacA targets myeloid cells in the gastric lamina propria to promote peripherally induced regulatory T-cell differentiation and persistent infection[J]. mBio, 2019, 10(2): e00261-219.
|
[33] |
Gebert B, Fischer W, Weiss E, et al. Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation[J]. Science, 2003, 301: 1099-1102.
|
[34] |
Luther J, Owyang SY, Takeuchi T, et al. Helicobacter pylori DNA decreases pro-inflammatory cytokine production by dendritic cells and attenuates dextran sodium sulphate-induced colitis[J]. Gut, 2011, 60(11): 1479-1486.
|
[35] |
Duramad O, Fearon KL, Chang B, et al. Inhibitors of TLR-9 act on multiple cell subsets in mouse and man in vitro and prevent death in vivo from systemic inflammation[J]. J Immunol, 2005, 174: 5193-5200.
|
[36] |
Samareh-Fekri M, Hashemi Bajgani SM, Shafahi A, et al. Detection of Helicobacter pylori in the bronchoalveolar lavage of patients with lung cancer using real-time PCR[J]. Jundishapur J Microbiol, 2016, 9(11): e32144.
|